Search results for: 'Preferred Destination for Clinical Trials'

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

The research service titled Eastern European markets for Ultrasound deals with the major trends in the ultrasound market. The research service provides an insight of the major industry challenges, the market drivers and restraints as well as the trends in technology development. Furthermore the research service also presents the emerging trends in ...

This study analyzes the market for adhesive bandages sold in the United States. The report pays special attention to the entire supply chain for the products, including substrate manufacturers and contract manufacturers. Market revenues are estimated for the United States, Europe, and Japan. The environmental impact of PVC used in many adhesive ban...

25 Sep 2025  |  Global  |  Technology Research

Growth Opportunities in Computational Quantum Chemistry for Accelerated Material Discovery

Harnessing Quantum Algorithms and Simulation Platforms to Transform Material R&D Across Industries

Infographics

×

As global industries confront increasing demands for sustainability, performance, and innovation in materials R&D, computational quantum chemistry is emerging as a crucial enabler in the coming years. By simulating matter at the electron level, quantum chemistry allows for highly accurate predictions of molecular behavior, driving breakthroughs in ...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

Medical triaging in hospitals has significant challenges, including long patient wait times, increased healthcare staff workload, risk of human error in triaging, and unsatisfactory patient outcomes, primarily due to manual triaging processes. These factors impact the quality and efficiency of patient triaging, creating an urgent need for innovativ...

03 Jun 2025  |  Global  |  Market Research

Advanced Visualization Solutions for Medical Imaging, Global, 2024–2029

Advanced Visualization Solutions for Cardiovascular and Neurology Conditions are Driving Transformational Growth

Infographics

×

The medical imaging industry is undergoing significant changes as it grapples with escalating challenges, including the surge in imaging exams, which leads to increasing workloads for radiologists; complex diagnostic tasks; and a global shortage of trained staff, placing a growing burden on both radiologists and healthcare systems.In response, tech...

The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve q...